EVONILE PHARMA Q2 FY27 ; NET LOSS ₹77.54 CR VS PROFIT ₹24.22 CR (YOY), PROFIT ₹32.21 CR (QOQ)

REVENUE DOWN 37.95% AT ₹56.05 CR (YOY), DOWN 46.01% (QOQ) EBITDA LOSS ₹31.82 CR VS PROFIT ₹23.88 CR (YOY), PROFIT ₹34.91 CR (QOQ) MARGINS AT -56.77% VS 26.44% (YOY), 33.63% (QOQ)

← Back to feed